# Why Are Cannabis Billboards Still Visible Despite New York’s Ban? > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-advertising-regulations-new-york-billboard-ban/ > **Published:** 2026-03-24T21:01:51-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:39:59-04:00 > **Clinical Summary:** Explore cannabis advertising regulations and why billboards remain despite New York's ban, impacting patient education and consumer protection. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PolicyPatient EducationRegulationMedical CannabisConsumer Protection Why This Matters Cannabis advertising regulations directly impact patient access to accurate information and clinical decision-making. When advertising rules are inconsistently enforced, patients may encounter misleading claims or unvetted products, complicating evidence-based treatment discussions. Clinical Summary New York law prohibits cannabis advertising in certain formats and locations, yet enforcement appears inconsistent based on continued billboard presence. This regulatory gap creates a disconnect between intended consumer protections and actual market practices. The clinical implications center on information quality and patient safety rather than the advertising medium itself. Dr. Caplan’s Take “Inconsistent advertising enforcement doesn’t change my clinical approach, but it does mean I spend more time helping patients distinguish between marketing claims and medical evidence. Clear regulations protect both patients and legitimate operators.” Clinical Perspective 🧠 Clinicians should prepare for patients who may have encountered unregulated advertising claims. Focus discussions on peer-reviewed evidence rather than marketing messages. This enforcement inconsistency underscores the importance of physician-guided [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) rather than consumer-driven product selection. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Why%20are%20there%20still%20cannabis%20billboards%20if%20they%27re%20banned%20under%20New%20York%20law%3F%20-%20...%20%40drcaplan&url=https%3A//www.youtube.com/watch%3Fv%3DZFSHlf4d7Nw)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.youtube.com/watch%3Fv%3DZFSHlf4d7Nw)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Why%20are%20there%20still%20cannabis%20billboards%20if%20they%27re%20banned%20under%20New%20York%20law%3F%20-%20...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.youtube.com/watch%3Fv%3DZFSHlf4d7Nw)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.youtube.com/watch?v=ZFSHlf4d7Nw](https://www.youtube.com/watch?v=ZFSHlf4d7Nw) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What type of cannabis-related content does this article cover?](#What_type_of_cannabis-related_content_does_this_article_cover) - [Why is this article marked as “New”?](#Why_is_this_article_marked_as_8220New8221) - [Who should pay attention to this type of cannabis news?](#Who_should_pay_attention_to_this_type_of_cannabis_news) - [What does “Notable Clinical Interest” mean for practitioners?](#What_does_8220Notable_Clinical_Interest8221_mean_for_practitioners) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned a Clinical Relevance rating of #70, indicating “Notable Clinical Interest.” This means it contains emerging findings or policy developments that healthcare professionals should monitor closely. #### What type of cannabis-related content does this article cover? The article focuses on policy, regulation, patient education, and medical cannabis topics. It appears to be from CED Clinic’s cannabis news section, suggesting clinical and regulatory relevance. #### Why is this article marked as “New”? The “New” designation indicates this is recently published content. This ensures healthcare providers are aware of the most current developments in cannabis policy and regulation. #### Who should pay attention to this type of cannabis news? Healthcare professionals, particularly those involved in [medical cannabis treatment](https://cedclinic.com/medical-cannabis-eligibility-book-appointment/), should monitor this content. The clinical relevance rating suggests it contains information important for patient care and practice management. #### What does “Notable Clinical Interest” mean for practitioners? This rating indicates the content contains emerging findings or policy developments worth monitoring closely. Practitioners should review this information as it may impact their clinical practice or patient education approaches. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Why are there still cannabis billboards if they’re banned under New York law? – YouTube”, “url”: “https://www.youtube.com/watch?v=ZFSHlf4d7Nw”, “datePublished”: “2026-03-24T23:03:09Z”, “about”: “why there still cannabis billboards if”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Good Question: Why are there still cannabis billboards in Rochester if they're banned?](https://cedclinic.com/cannabis-advertising-enforcement-gaps-rochester/) Explore the regulatory challenges behind cannabis billboard bans in Rochester and their impact on consumers. [Read More](https://cedclinic.com/cannabis-advertising-enforcement-gaps-rochester/) [Does Cannabis Legalization Spur More Innovation Than Medical Research?](https://cedclinic.com/cannabis-innovation-and-medical-research-balance/) An analysis of how [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) influences innovation compared to [medical research](https://cedclinic.com/cb2-receptor-agonist-parkinsons/) advancements. [Discover Insights](https://cedclinic.com/cannabis-innovation-and-medical-research-balance/) [FDA's New Hemp CBD Enforcement Move Is Encouraging, But Congress Still Needs To Act](https://cedclinic.com/fda-hemp-product-enforcement-cbd-regulation-impact/) Review recent FDA enforcement actions on hemp CBD and the ongoing need for legislative clarity. [Learn More](https://cedclinic.com/fda-hemp-product-enforcement-cbd-regulation-impact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).